🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.

Investigational Treatment Gaining Traction Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these accounts privately for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a robust market exists on messaging services, where groups with numerous of participants share “before and after” images, injection guides and assertions of next-day UK delivery. Sellers market the drug there before directing buyers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Express Concerns

However, physicians and pharmacists have cautions that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in individuals injecting products of uncertain source.

Some professionals said the demand for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate medicines, marketing, and consumer laws, risking fines, prosecution or prison.

Service Reaction and Content Removal

According to TikTok, the platform has removed violative content and prohibited related keywords and search suggestions. The organization said it was committed to keeping the service safe and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Research also found groups with up to 9,000 members selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of members, populated with images of weight loss, glowing reviews and detailed instructions for mixing or injecting at residence.

Within moments of joining one group, a vendor shared WhatsApp details, where most purchases take place. The seller provided an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, medical conditions or past usage.

Product Details and Pricing

Inside these groups, posts display black plastic parcels with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for the messaging service stated it actively monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they can’t verify. Even if the research behind retatrutide is valid, these online products may not contain what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for approved slimming drugs such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.

Her team has already seen individuals injured by self-injection from unverified suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may expose patients to possibly serious medical dangers”.